| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.3 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.3 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.058 | 0.3 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.3 |